skip to content »

Translational Biology & Molecular Medicine

Houston, Texas

Benchtop, Research, Bedside and Application
Translational Biology & Molecular Medicine Graduate Program
not shown on screen

James Versalovic, M.D., Ph.D.

James Versalovic

Milton J. Finegold Professor
Department of Pathology and Immunology

Phone: 832-824-2213
Fax: 832-825-0164
E-mail: jamesv@bcm.edu

Education

  • Ph.D., Cell and Molecular Biology, Baylor College of Medicine, Houston, TX
  • M.D., Baylor College of Medicine, Houston, TX
  • Postdoctoral Fellow, Baylor College of Medicine, Houston, TX
  • Fellowship, Pathology, Harvard Medical School, Boston, MA
  • Residency, Clinical Pathology, Massachusetts General Hospital, Boston, MA
  • Postdoctoral Fellow, Massachusetts Institute of Technology, Cambridge, MA

Research Interests

  • Genomics of beneficial bacteria
  • Molecular mechanisms of probiotic intestinal interactions
  • Human Microbiome Project

Clinical Focus

  • Microbiology
  • Molecular pathology
  • Gastroenterology

Selected Publications

  • Thomas CM, Versalovic J. Probiotics-host communication: Modulation of signaling pathways in the intestine. Gut Microbes. 2010. 1(3):1-16.
  • Jones SE, Versalovic J. Probiotic Lactobacillus reuteri biofilms produce antimicrobial and anti-inflammatory factors. BMC Microbiol. 2009. 9:35.
  • Petrosino JF, Highlander S, Luna RA, Gibbs RA, Versalovic J. Metagenomic pyrosequencing and microbial identification. Clin Chem. 2009. 55(5):856-66.
  • Preidis GA, Versalovic J. Targeting the human microbiome with antibiotics, probiotics, and prebiotics: gastroenterology enters the metagenomics era. Gastroenterology. 2009. 136(6):2015-31.
  • Hsieh MH, Versalovic J. The human microbiome and probiotics: implications for pediatrics. Curr Probl Pediatr Adolesc Health Care. 2008. 38(10):309-27.
  • Spinler JK, Taweechotipatr M, Rognerud CL, Ou CN, Tumwasorn S, Versalovic J. Human-derived probiotic Lactobacillus reuteri demonstrate antimicrobial activities targeting diverse enteric bacterial pathogens. Anaerobe. 2008.14(3):166-71.

E-mail this page to a friend